A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality

Authors

X. Ye

Published

December 1, 2024

Abstract

To assess the efficacy and safety of Vortioxetine and Escitalopram in improving cognition in patients with major depressive disorder (MDD).

Supporters

Support the authors with ResearchCoin

Journal

Neuropsychiatric Disease and Treatment

Topics

DOI

10.2147/ndt.s491768

License

CC-BY-NC

A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality

Authors

X. Ye

Published

December 1, 2024

Abstract

To assess the efficacy and safety of Vortioxetine and Escitalopram in improving cognition in patients with major depressive disorder (MDD).

Supporters

Support the authors with ResearchCoin

Journal

Neuropsychiatric Disease and Treatment

Topics

DOI

10.2147/ndt.s491768

License

CC-BY-NC

Paper

Paper

Paper

Paper

A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality

Abstract

Supporters

Journal

Topics

DOI

License

A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality

Abstract

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License